Barclays’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92K | Buy |
+150,000
| New | +$92K | ﹤0.01% | 3842 |
|
|
2025
Q1 | – | Sell |
-14
| Closed | – | – | 4352 |
|
|
2024
Q4 | $0 | Sell |
14
-37
| -73% | – | ﹤0.01% | 4347 |
|
|
2024
Q3 | $0 | Sell |
51
-345
| -87% | – | ﹤0.01% | 4307 |
|
|
2024
Q2 | $0 | Sell |
396
-37,303
| -99% | – | ﹤0.01% | 4165 |
|
|
2024
Q1 | $88K | Sell |
37,699
-4,098
| -10% | -$9.57K | ﹤0.01% | 3683 |
|
|
2023
Q4 | $79K | Buy |
41,797
+36,331
| +665% | +$68.7K | ﹤0.01% | 3764 |
|
|
2023
Q3 | $7K | Sell |
5,466
-224,687
| -98% | -$288K | ﹤0.01% | 4070 |
|
|
2023
Q2 | $559K | Buy |
230,153
+211,815
| +1,155% | +$514K | ﹤0.01% | 2526 |
|
|
2023
Q1 | $105K | Sell |
18,338
-80,325
| -81% | -$460K | ﹤0.01% | 3496 |
|
|
2022
Q4 | $882K | Buy |
98,663
+16,256
| +20% | +$145K | ﹤0.01% | 2223 |
|
|
2022
Q3 | $1.17M | Buy |
82,407
+80,987
| +5,703% | +$1.15M | ﹤0.01% | 2017 |
|
|
2022
Q2 | $21K | Sell |
1,420
-2,764
| -66% | -$40.9K | ﹤0.01% | 4062 |
|
|
2022
Q1 | $84K | Buy |
+4,184
| New | +$84K | ﹤0.01% | 3746 |
|
|
2020
Q3 | – | Sell |
-599
| Closed | -$9K | – | 3703 |
|
|
2020
Q2 | $9K | Sell |
599
-126
| -17% | -$1.89K | ﹤0.01% | 3652 |
|
|
2020
Q1 | $5K | Sell |
725
-1,506
| -68% | -$10.4K | ﹤0.01% | 3544 |
|
|
2019
Q4 | $23K | Buy |
2,231
+1,004
| +82% | +$10.4K | ﹤0.01% | 3667 |
|
|
2019
Q3 | $76K | Sell |
1,227
-186
| -13% | -$11.5K | ﹤0.01% | 3530 |
|
|
2019
Q2 | $101K | Buy |
1,413
+967
| +217% | +$69.1K | ﹤0.01% | 3586 |
|
|
2019
Q1 | $21K | Buy |
446
+348
| +355% | +$16.4K | ﹤0.01% | 3901 |
|
|
2018
Q4 | $6K | Sell |
98
-478
| -83% | -$29.3K | ﹤0.01% | 3664 |
|
|
2018
Q3 | $61K | Sell |
576
-121
| -17% | -$12.8K | ﹤0.01% | 3661 |
|
|
2018
Q2 | $45K | Buy |
697
+503
| +259% | +$32.5K | ﹤0.01% | 3316 |
|
|
2018
Q1 | $13K | Buy |
+194
| New | +$13K | ﹤0.01% | 3907 |
|